SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-04-007780
Filing Date
2004-03-15
Accepted
2004-03-12 18:33:34
Documents
7
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2130889z10-k.htm 10-K 605566
3 EXHIBIT 10.34 a2130889zex-10_34.txt EX-10.34 53583
4 EXHIBIT 18 a2130889zex-18.txt EX-18 1653
5 EXHIBIT 23.1 a2130889zex-23_1.txt EX-23.1 809
6 EXHIBIT 31.1 a2130889zex-31_1.txt EX-31.1 3690
7 EXHIBIT 31.2 a2130889zex-31_2.txt EX-31.2 3764
8 EXHIBIT 32 a2130889zex-32.txt EX-32 1276
  Complete submission text file 0001047469-04-007780.txt   672624
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-15006 | Film No.: 04667350
SIC: 2835 In Vitro & In Vivo Diagnostic Substances